De Lucca FL - Search Results

1

Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil.

de Oliveira Cavassin GG, De Lucca FL, Delgado André N, Covas DT, Pelegrinelli Fungaro MH, Voltarelli JC, Watanabe MA. de Oliveira Cavassin GG, et al. Among authors: de lucca fl. Blood Cells Mol Dis. 2004 Jul-Aug;33(1):90-3. doi: 10.1016/j.bcmd.2004.04.008. Blood Cells Mol Dis. 2004. PMID: 15223017

2

Expression of noncoding mRNA in human blood cells activated with synthetic peptide of HIV.

Amarante MK, De Lucca FL, de Oliveira CE, Pelegrinelli Fungaro MH, Reiche EM, Muxel SM, Ehara Watanabe MA. Amarante MK, et al. Among authors: de lucca fl, de oliveira ce. Blood Cells Mol Dis. 2005 Sep-Oct;35(2):286-90. doi: 10.1016/j.bcmd.2005.06.004. Blood Cells Mol Dis. 2005. PMID: 16027015

3

Non-coding transcript in T cells (NTT): antisense transcript activates PKR and NF-kappaB in human lymphocytes.

Delgado André N, De Lucca FL. Delgado André N, et al. Among authors: de lucca fl. Blood Cells Mol Dis. 2008 Mar-Apr;40(2):227-32. doi: 10.1016/j.bcmd.2007.08.005. Epub 2007 Oct 24. Blood Cells Mol Dis. 2008. PMID: 17928244

4

Knockdown of chemokine receptor CXCR4 gene by RNA interference: Effects on the B16-F10 melanoma growth.

André ND, Silva VA, Watanabe MA, De Lucca FL. André ND, et al. Among authors: de lucca fl. Oncol Rep. 2016 Apr;35(4):2419-24. doi: 10.3892/or.2016.4620. Epub 2016 Feb 12. Oncol Rep. 2016. PMID: 26883290

5

Intratumoral injection of PKR shRNA expressing plasmid inhibits B16-F10 melanoma growth.

André ND, Silva VA, Watanabe MA, De Lucca FL. André ND, et al. Among authors: de lucca fl. Oncol Rep. 2014 Nov;32(5):2267-73. doi: 10.3892/or.2014.3410. Epub 2014 Aug 18. Oncol Rep. 2014. PMID: 25175769

6

[Corrigendum] Intratumoral injection of PKR shRNA expressing plasmid inhibits B16-F10 melanoma growth.

André ND, Silva VAO, Watanabe MAE, De Lucca FL. André ND, et al. Among authors: de lucca fl. Oncol Rep. 2018 Nov;40(5):3113. doi: 10.3892/or.2018.6646. Epub 2018 Aug 14. Oncol Rep. 2018. PMID: 30132553 Free PMC article.

7

Knockdown of PKR expression by RNAi reduces pulmonary metastatic potential of B16-F10 melanoma cells in mice: possible role of NF-kappaB.

Delgado André N, De Lucca FL. Delgado André N, et al. Among authors: de lucca fl. Cancer Lett. 2007 Dec 8;258(1):118-25. doi: 10.1016/j.canlet.2007.08.021. Cancer Lett. 2007. PMID: 17936498

8

Anti-tumor effect of splenocytes treated with RNA from animals immunized with bovine myelin basic protein.

Watanabe MA, De Lucca FL. Watanabe MA, et al. Among authors: de lucca fl. Cell Mol Biol (Noisy-le-grand). 1996 Mar;42(2):249-54. Cell Mol Biol (Noisy-le-grand). 1996. PMID: 8696262

9

In vivo knockdown of CXCR4 using jetPEI/CXCR4 shRNA nanoparticles inhibits the pulmonary metastatic potential of B16‑F10 melanoma cells.

André ND, Silva VA, Ariza CB, Watanabe MA, De Lucca FL. André ND, et al. Among authors: de lucca fl. Mol Med Rep. 2015 Dec;12(6):8320-6. doi: 10.3892/mmr.2015.4487. Epub 2015 Oct 26. Mol Med Rep. 2015. PMID: 26498029

10

Antitumor activity induced by regulatory RNA: possible role of RNA-dependent protein kinase and nuclear factor-kappaB.

Watanabe MA, Rodrigues Souza L, Murad JM, De Lucca FL. Watanabe MA, et al. Among authors: de lucca fl. Eur J Pharmacol. 2003 Apr 4;465(3):205-10. doi: 10.1016/s0014-2999(03)01480-8. Eur J Pharmacol. 2003. PMID: 12681431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters